{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:15Z","timestamp":1786120275865,"version":"build-2736575974"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/jcp.0b013e318234ee84","type":"journal-article","created":{"date-parts":[[2011,10,21]],"date-time":"2011-10-21T04:09:11Z","timestamp":1319170151000},"page":"705-711","source":"Crossref","is-referenced-by-count":24,"title":["Polymorphisms of INSIG2, MC4R, and LEP Are Associated With Obesity- and Metabolic-Related Traits in Schizophrenic Patients"],"prefix":"10.1097","volume":"31","author":[{"given":"Po-Hsiu","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Feng","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yau-Sheng","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mong-Lian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1-2","key":"R1-5-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(99)00191-7","article-title":"Mortality and causes of death in schizophrenia in Stockholm County, Sweden.","volume":"45","author":"Osby","year":"2000","journal-title":"Schizophr Res"},{"issue":"15","key":"R2-5-20210128","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1002\/cncr.24383","article-title":"Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study.","volume":"115","author":"Tran","year":"2009","journal-title":"Cancer"},{"issue":"7","key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4088\/JCP.08m04508","article-title":"Metabolic risk factors in drug-naive patients with first-episode psychosis.","volume":"70","author":"Verma","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/01.yic.0000188215.84784.17","article-title":"High prevalence of the metabolic syndrome among a Swedish cohort of patients with schizophrenia.","volume":"21","author":"Hagg","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1745-0179-2-14","article-title":"Prevalence of diabetes, metabolic syndrome and metabolic abnormalities in schizophrenia over the course of the illness: a cross-sectional study.","volume":"2","author":"De Hert","year":"2006","journal-title":"Clin Pract Epidemiol Ment Health"},{"issue":"1","key":"R7-5-20210128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","article-title":"Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.","volume":"80","author":"McEvoy","year":"2005","journal-title":"Schizophr Res"},{"issue":"7","key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4088\/JCP.v68n0711","article-title":"Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey.","volume":"68","author":"Suvisaari","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1600-0447.2009.01401.x","article-title":"Prevalence of metabolic syndrome among patients with schizophrenia or schizoaffective disorder in Taiwan.","volume":"120","author":"Huang","year":"2009","journal-title":"Acta Psychiatr Scand"},{"issue":"suppl 1","key":"R10-5-20210128","first-page":"20","article-title":"Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.","volume":"68","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"13","key":"R11-5-20210128","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jpsychires.2009.03.002","article-title":"The incidence of metabolic syndrome and its reversal in a cohort of schizophrenic patients followed for one year.","volume":"43","author":"Schorr","year":"2009","journal-title":"J Psychiatr Res"},{"issue":"2","key":"R12-5-20210128","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.","volume":"160","author":"Ryan","year":"2003","journal-title":"Am J Psychiatry"},{"issue":"5","key":"R13-5-20210128","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1464-5491.2007.02092.x","article-title":"Impaired glucose tolerance in first-episode drug-naive patients with schizophrenia.","volume":"24","author":"Spelman","year":"2007","journal-title":"Diabet Med"},{"key":"R14-5-20210128","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1192\/bjp.184.47.s64","article-title":"Diabetes mellitus and schizophrenia: historical perspective.","volume":"184","author":"Kohen","year":"2004","journal-title":"Br J Psychiatry"},{"key":"R15-5-20210128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1192\/bjp.184.47.s67","article-title":"Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia.","volume":"184","author":"Bushe","year":"2004","journal-title":"Br J Psychiatry"},{"issue":"8636","key":"R16-5-20210128","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0140-6736(89)91392-5","article-title":"Family history of type 2 diabetes in schizophrenic patients.","volume":"1","author":"Mukherjee","year":"1989","journal-title":"Lancet"},{"issue":"12","key":"R17-5-20210128","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/sj.mp.4001537","article-title":"A genome wide linkage study of obesity as secondary effect of antipsychotics in multigenerational families of eastern Quebec affected by psychoses.","volume":"9","author":"Chagnon","year":"2004","journal-title":"Mol Psychiatry"},{"issue":"6","key":"R18-5-20210128","doi-asserted-by":"crossref","first-page":"863","DOI":"10.2217\/14622416.7.6.863","article-title":"Genetics of antipsychotic treatment emergent weight gain in schizophrenia.","volume":"7","author":"Muller","year":"2006","journal-title":"Pharmacogenomics"},{"issue":"5771","key":"R19-5-20210128","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1126\/science.1124779","article-title":"A common genetic variant is associated with adult and childhood obesity.","volume":"312","author":"Herbert","year":"2006","journal-title":"Science"},{"issue":"18","key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"7106","DOI":"10.1073\/pnas.0401715101","article-title":"Hepatic insig-1 or -2 overexpression reduces lipogenesis in obese Zucker diabetic fatty rats and in fasted\/refed normal rats.","volume":"101","author":"Takaishi","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"R21-5-20210128","doi-asserted-by":"crossref","first-page":"e2872","DOI":"10.1371\/journal.pone.0002872","article-title":"Non-replication of genome-wide based associations between common variants in INSIG2 and PFKP and obesity in studies of 18,014 Danes.","volume":"3","author":"Andreasen","year":"2008","journal-title":"PLoS One"},{"key":"R22-5-20210128","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2350-10-143","article-title":"A tagging SNP in INSIG2 is associated with obesity-related phenotypes among Samoans.","volume":"10","author":"Deka","year":"2009","journal-title":"BMC Med Genet"},{"issue":"8","key":"R23-5-20210128","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.metabol.2009.11.005","article-title":"Common INSIG2 polymorphisms are associated with age-related changes in body size and high-density lipoprotein cholesterol from young adulthood to middle age.","volume":"59","author":"Fornage","year":"2010","journal-title":"Metabolism"},{"issue":"9","key":"R24-5-20210128","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10038-008-0317-8","article-title":"INSIG2 gene rs7566605 polymorphism is associated with severe obesity in Japanese.","volume":"53","author":"Hotta","year":"2008","journal-title":"J Hum Genet"},{"issue":"3","key":"R25-5-20210128","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1017\/S0007114508006557","article-title":"The single nucleotide polymorphism upstream of insulin-induced gene 2 (INSIG2) is associated with the prevalence of hypercholesterolaemia, but not with obesity, in Japanese American women.","volume":"101","author":"Oki","year":"2009","journal-title":"Br J Nutr"},{"issue":"5","key":"R26-5-20210128","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1210\/jc.2007-1850","article-title":"Insulin-induced gene 2 involvement in human adipocyte metabolism and body weight regulation.","volume":"93","author":"Krapivner","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"R27-5-20210128","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/ng.140","article-title":"Common variants near MC4R are associated with fat mass, weight and risk of obesity.","volume":"40","author":"Loos","year":"2008","journal-title":"Nat Genet"},{"issue":"6","key":"R28-5-20210128","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/ng.156","article-title":"Common genetic variation near MC4R is associated with waist circumference and insulin resistance.","volume":"40","author":"Chambers","year":"2008","journal-title":"Nat Genet"},{"issue":"12","key":"R29-5-20210128","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa022050","article-title":"Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene.","volume":"348","author":"Farooqi","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"R30-5-20210128","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3945\/ajcn.2009.27781","article-title":"Obesity genes identified in genome-wide association studies are associated with adiposity measures and potentially with nutrient-specific food preference.","volume":"90","author":"Bauer","year":"2009","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"R31-5-20210128","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1210\/jc.2009-1465","article-title":"Obesity susceptibility genetic variants identified from recent genome-wide association studies: implications in a Chinese population.","volume":"95","author":"Cheung","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"R32-5-20210128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ijo.2008.279","article-title":"Common genetic variation near MC4R is associated with eating behaviour patterns in European populations.","volume":"33","author":"Stutzmann","year":"2009","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"R33-5-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/oby.2007.21","article-title":"Association of the MC4R V103I polymorphism with the metabolic syndrome: the KORA Study.","volume":"16","author":"Heid","year":"2008","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"R34-5-20210128","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1530\/eje.0.1430293","article-title":"Human leptin: from an adipocyte hormone to an endocrine mediator.","volume":"143","author":"Wauters","year":"2000","journal-title":"Eur J Endocrinol"},{"issue":"suppl 1","key":"R35-5-20210128","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.2337\/diabetes.53.2007.S152","article-title":"Leptin effects on pancreatic beta-cell gene expression and function.","volume":"53","author":"Seufert","year":"2004","journal-title":"Diabetes"},{"issue":"7","key":"R36-5-20210128","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0092-8674(95)90151-5","article-title":"Identification and expression cloning of a leptin receptor, OB-R.","volume":"83","author":"Tartaglia","year":"1995","journal-title":"Cell"},{"issue":"8","key":"R37-5-20210128","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/ijo.2008.68","article-title":"Common SNPs in LEP and LEPR associated with birth weight and type 2 diabetes-related metabolic risk factors in twins.","volume":"32","author":"Souren","year":"2008","journal-title":"Int J Obes (Lond)"},{"issue":"6","key":"R38-5-20210128","doi-asserted-by":"crossref","first-page":"e6034","DOI":"10.1371\/journal.pone.0006034","article-title":"Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array.","volume":"4","author":"Sober","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"R39-5-20210128","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/met.2008.0029","article-title":"Association between the Gln223Arg polymorphism of the leptin receptor and metabolic syndrome in free-living community elderly.","volume":"7","author":"Gottlieb","year":"2009","journal-title":"Metab Syndr Relat Disord"},{"issue":"2","key":"R40-5-20210128","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1399-0004.2008.01033.x","article-title":"Genetic variations in the leptin and leptin receptor genes are associated with type 2 diabetes mellitus and metabolic traits in the Korean female population.","volume":"74","author":"Han","year":"2008","journal-title":"Clin Genet"},{"issue":"3","key":"R41-5-20210128","first-page":"1","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.","volume":"7","author":"Speliotes","year":"2010","journal-title":"PLoS Genet"},{"key":"R42-5-20210128","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000321537","article-title":"Chipping away the 'missing heritability': GIANT steps forward in the molecular elucidation of obesity-but still lots to go.","volume":"3","author":"Hebebrand","year":"2010","journal-title":"Obes Facts"},{"issue":"3","key":"R43-5-20210128","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.mp.4002133","article-title":"Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects?","volume":"14","author":"Le Hellard","year":"2009","journal-title":"Mol Psychiatry"},{"issue":"4","key":"R44-5-20210128","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.mp.4001956","article-title":"Is rs7566605, a SNP near INSIG2, associated with body mass in a randomized clinical trial of antipsychotics in schizophrenia?","volume":"12","author":"Skelly","year":"2007","journal-title":"Mol Psychiatry"},{"issue":"1","key":"R45-5-20210128","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/JCP.0b013e31819359be","article-title":"Polymorphisms of the LEP- and LEPR gene and obesity in patients using antipsychotic medication.","volume":"29","author":"Gregoor","year":"2009","journal-title":"J Clin Psychopharmacol"},{"issue":"5","key":"R46-5-20210128","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2337\/diacare.27.5.1182","article-title":"Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians?","volume":"27","author":"Tan","year":"2004","journal-title":"Diabetes Care"},{"key":"R47-5-20210128","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and -cell function from fasting plasma glucose and insulin concentrations in man.","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"issue":"1-3","key":"R48-5-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.schres.2008.01.028","article-title":"Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review.","volume":"101","author":"De Herta","year":"2008","journal-title":"Schizophr Res"},{"issue":"7","key":"R49-5-20210128","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/ajmg.b.30743","article-title":"Candidate genes for schizophrenia: a survey of association studies and gene ranking.","volume":"147B","author":"Sun","year":"2008","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"10","key":"R50-5-20210128","doi-asserted-by":"crossref","first-page":"e1000694","DOI":"10.1371\/journal.pgen.1000694","article-title":"Meta-analysis of the INSIG2 association with obesity including 74,345 individuals: does heterogeneity of estimates relate to study design?","volume":"5","author":"Heid","year":"2009","journal-title":"PLoS Genet"},{"issue":"8","key":"R51-5-20210128","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1038\/oby.2009.94","article-title":"INSIG2 SNPs associated with obesity and glucose homeostasis traits in Hispanics: the IRAS Family Study.","volume":"17","author":"Talbert","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"R52-5-20210128","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cell.2005.08.035","article-title":"Divergence of melanocortin pathways in the control of food intake and energy expenditure.","volume":"123","author":"Balthasar","year":"2005","journal-title":"Cell"},{"issue":"11","key":"R53-5-20210128","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1172\/JCI31743","article-title":"The central melanocortin system directly controls peripheral lipid metabolism.","volume":"117","author":"Nogueiras","year":"2007","journal-title":"J Clin Invest"},{"issue":"5","key":"R54-5-20210128","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00109-009-0451-6","article-title":"Combined effects of MC4R and FTO common genetic variants on obesity in European general populations.","volume":"87","author":"Cauchi","year":"2009","journal-title":"J Mol Med"},{"issue":"10","key":"R55-5-20210128","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1038\/oby.2009.233","article-title":"Impact of variation near MC4R on whole-body fat distribution, liver fat, and weight loss.","volume":"17","author":"Haupt","year":"2009","journal-title":"Obesity (Silver Spring)"},{"issue":"3","key":"R56-5-20210128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/ajcn\/88.3.797","article-title":"Association of the melanocortin-4 receptor V103I polymorphism with dietary intake in severely obese persons.","volume":"88","author":"Pichler","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R57-5-20210128","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/27376","article-title":"Leptin and the regulation of body weight in mammals.","volume":"395","author":"Friedman","year":"1998","journal-title":"Nature"},{"issue":"7","key":"R58-5-20210128","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.peptides.2009.04.008","article-title":"Hypothalamic melanocortin signaling and leptin resistance-perspective of therapeutic application for obesity-diabetes syndrome.","volume":"30","author":"Masuzaki","year":"2009","journal-title":"Peptides"},{"key":"R59-5-20210128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pnpbp.2010.11.014","article-title":"Gender differences in the effects of peroxisome proliferator-activated receptor 2 gene polymorphisms on metabolic adversity in patients with schizophrenia or schizoaffective disorder.","volume":"35","author":"Chen","year":"2011","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201112000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:24:17Z","timestamp":1786047857000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201112000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e318234ee84","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}